AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting ...

Research shows Fc–IL-4 revitalizes exhausted CD8+ T cells, boosting antitumor responses and highlighting the potential of ...

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Human innate immune cells that “remember” previous stimulation could provide new insights into chronic inflammatory diseases.

Researchers sought to determine whether CAR-T therapy would be effective in patients with RRMM and light chain amyloidosis.

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

Immunotherapeutic approaches have substantially improved the treatment of patients with advanced malignancies. However, most ...

Epkinly showed an overall response rate of 82% with 62.5% of patients achieving complete response. 65% of patients had grade 1-2 cytokine release syndrome (CRS), though severe cases (grade 3) were ...

Protein complexes are crucial orchestrators of biological processes that hold immense therapeutic potential. However, their instability and transient nature have hindered practical applications. This ...

September 30, 2024) In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...